The Wilson Disease copper balance study
The aim of this clinical study in people with Wilson Disease is to find out whether Alexion’s investigational product is able to help restore copper balance by promoting the removal of more copper from the body than is taken in through food and drink. This clinical study is currently recruiting, and if you would like to learn more, please contact Celerion Lincoln, Nebraska, at email: WilsonStudyInfo@celerion.com or call 866-445-7033. This clinical study is sponsored by Alexion Pharmaceuticals, Inc.
Share This Story, Choose Your Platform!